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and a skin lesion or portal of entry should be heeded as a
potential warning, especially in patients with a history of
exposure to seawater.
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Paracoccus  yeei  peritonitis  in p
Peritonitis  causada  por  Paracoccus
Dear Editor,
Peritonitis is deﬁned as peritoneal inﬂammation caused b
microorganisms, with the presence of cloudy peritoneal ﬂuid
a leukocyte count of more  than 100 per microlitre and leuko
cytes accounting for more  than 50% of polymorphonuclea
cells. It remains the most signiﬁcant complication derivin
from the dialysis technique itself. It is generally caused b
Gram-positive skin bacteria such as Staphylococcus epidermidi
and Staphylococcus aureus,  or by enterobacteria and fung
An intact peritoneum and the defence mechanisms of th
mesothelium are probably the most signiﬁcant barriers tha
help prevent the development of peritonitis. Prevention is th
fundamental weapon, and the routes by which microorgan
isms enter the peritoneal cavity should be acted on: peritonea
access, connection systems, dialysis solutions and examina
tions that help enable infection.
Paracoccus yeei is a non-fermenting bacterium in the envi
ronment that is present in soil. It is the bacterium that cause
the episode of peritonitis in the case that we are reporting.
Our case is a 46-year-old woman diagnosed with adult poly
cystic kidney disease, on a regimen of automated peritonea
dialysis for the last 3 years, with no prior episodes of peritoni-
tis. The patient lived with a small dog she routinely take out
for walks.
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itoneal  dialysis
ei  en  diálisis  peritoneal
She visited the dialysis unit because she noticed cloudy
ﬂuid in the peritoneal efﬂuent drainage. There was no feve
or nausea, and her bowel movements were normal. She had
slight abdominal discomfort, and an examination showed
signs of peritoneal irritation. A peritoneal ﬂuid cell count wa
performed and found 790 leukocytes/mcl, with 75% polymor
phonuclear cells. Samples were sent for the performance o
a Gram stain, and cultures in blood culture and conventiona
media. A diagnosis of peritonitis was conﬁrmed and treatmen
was started according to our site’s protocol, with intraperi
toneal vancomycin and ceftazidime. Empirical treatment o
peritonitis was to be done with a combination of broad spec
trum antibiotics targeting Gram-positive and Gram-negative
microorganisms. The patient continued on an outpatien
regimen, since her general condition was good, with daily self
administration of intraperitoneal ceftazidime and visits to the
hospital to undergo follow-up cell counts. At 48 h she received
a positive culture in a blood culture medium for Paracoccus yeei
No bacteria were seen on a Gram stain, and a conventiona
culture was negative. Peritonitis results in morbidity and mor
tality, and is a cause of hospitalization in the most impairedik I, Marin˜o S, Lucas C, Monfá E, et al. Paracoccus yeei peritonitis in
basis, as in our case.
Paracoccus yeei was formerly classiﬁed as a eugonic oxidizer
group 2 (EO-2) strain. In 2003, new molecular techniques iden-
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decrease in bone resorption of trabecular and cortical bone. It46  n e f r o l o g i a. 2 0
ﬁed this new species. It consists of small non-fermenting
robic Gram-negative coccobacilli, with O-shaped morphol-
gy. The bacterium is catalase- and oxidase-positive. Its
henotype is identiﬁed by PCR and conﬁrmed with 16S rRNA
ne sequencing. It was identiﬁed for the ﬁrst time in the per-
oneal ﬂuid in a peritoneal dialysis patient in Pennsylvania1
d subsequently anecdotally identiﬁed in other cases.2 It
ainly affects immunodepressed patients and may cause skin
fections,3 myocarditis,4 arthritis,5 keratitis and corneal graft
jection.6,7
It is found naturally in soil. Given that our patient had
small dog, we  thought this could have brought the bacte-
a to her house, that the patient could have contaminated
erself with it if she failed to comply with strict hand-
ashing and it could have passed to the peritoneum during
nnection.
The Paracoccus yeei bacterium is sensitive to beta-lactams,
pecially aminopenicillins and carbapenems, as well as
ird-generation cephalosporins. Intraperitoneal administra-
on of antibiotics achieves improvement, as there is a higher
ncentration of bacteria at the infected site, and easily leads
 eradication of the bacterium.
The course of our patient’s peritonitis was good, with a
adual drop in leukocytes in the efﬂuent from the time when
e received the culture. Vancomycin was suspended and
eatment was completed with ceftazidime for 14 days.
This bacterium is rarely identiﬁed in clinical samples. Ani-
als such as a horse8 or, in our case, a dog may be the vehicle
r human contamination.
We believe this to be the ﬁrst reported case of Paracoccus
ei peritonitis in Spain.
e  f  e  r  e  n  c  e  s
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evere  hypocalcemia  following
atient with  chronic  kidney dis
ipocalcemia  severa  tras  la  admini
enosumab  en  un  paciente  con  ins
ear Editor:enosumab is a human monoclonal antibody (IgG2) that binds
ith great afﬁnity and speciﬁcity to RANKL and blocks activa-
on of RANK, its receptor, on the surface of osteoclasts and
Please cite this article as: Monge Rafael P, Arias M, Fernández-Fresned
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eir precursors, thereby reducing their activity and causing ao G. Hipocalcemia severa tras la administración de una dosis de
. 2016;36:446–448.
 used for the treatment of osteoporosis and is administered
ery 6 months.1,2 It is not necessary to adjust the dose in
nal failure, but there is an increased risk of hypocalcaemia.1
